TITLE

Prostaglandin E1 on Infradiaphragmatic Type of Total Anomalous Pulmonary Venous Connection - a Case Report

AUTHOR(S)
Cirstoveanu, Catalin; Cinteza, Eliza; Marcu, Veronica; Bizubac, Mihaela; Balomir, Alina; Barascu, Ileana; Coman, Mariana; Balgradean, Mihaela
PUB. DATE
June 2012
SOURCE
Romanian Journal of Medical Practice;2012, Vol. 7 Issue 2, p167
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
We present the case of a newborn with severe pulmonary hypertension, diagnosed with infradiaphragmatic type of total anomalous pulmonary venous connection (TAPVC). The onset was in the first 10 days of life. Diagnosis was made by echocardiography and AngioCT. The pulmonary venous collector was surgically implanted into the left atrium in Germany, but the next month after surgery he developed cardiopulmonary insufficiency and died several days later. We would like to emphasize the importance of prostaglandin E1 administration in this particular case of infradiaphragmatic type of TAPVC and its usefulness in patient's stabilization until surgery. The prognosis in TAPVC, infradiaphragmatic type, is poor and is related mainly to the existence of pulmonary venous obstruction.
ACCESSION #
77845083

 

Related Articles

  • Changes of Sequestered Leukocytes and Platelets by Inhalation Prostaglandin E[sub 1] in the Pulmonary Microvasculature of Rats with Monocrotaline-Induced Pulmonary Hypertension. Kato, Shiro; Kishiro, Izumi; Sugimura, Hiroyuki; Machida, Suguru; Fuse, Daisuke; Kaneko, Noboru // Journal of Vascular Research;2002, Vol. 39 Issue 1, p83 

    The role of leukocytes (WBCs) and platelets (PLTs) in the pulmonary circulation may be important in the development of monocrotaline (MCT)-induced pulmonary hypertension in rats. We investigated the suppressive effects of long-term prostaglandin E[sub 1] (PGE[sub 1] ) aerosol on the changes in...

  • Suppressive Effect of Prostaglandin E[sub 1] on Pulmonary Hypertension Induced by Monocrotaline... Sakuma, F.; Miyata, M.; Kasukawa, R. // Lung;1999, Vol. 177 Issue 2, p77 

    Studies the effect of prostaglandin E[sub 1] on monocrotaline-induced pulmonary hypertension and cytokine production by macrophages during the monocrotaline induction of pulmonary hypertension. Effectiveness of administering prostaglandin E[sub 1] in the treatment of some forms of pulmonary...

  • A suggested new surgical classification for mixed totally anomalous pulmonary venous connection. Chowdhury, Ujjwal K.; Malhotra, Amber; Kothari, Shyam S.; Reddy, Sri Krishna; Mishra, Anand K.; Pradeep, Kizakke K.; Venugopal, Panangipalli // Cardiology in the Young;Aug2007, Vol. 17 Issue 4, p342 

    The morphologic variations of mixed totally anomalous pulmonary venous connection are many and varied. In this review, we give an account of all cases previously described as mixed totally anomalous pulmonary venous connection, analyzing in detail those cases where an accurate anatomical...

  • Therapy with intermittent pulse cyclophosphamide for pulmonary hypertension associated with systemic lupus erythematosus. Gonzalez-Lopez, L.; Cardona-Mu�oz, E. G.; Celis, A.; la Torre, I. Garc�a-de; Orozco-Barocio, G.; Salazar-Paramo, M.; Garcia-Gonzalez, C.; Garcia-Gonzalez, A.; Sanchez-Ortiz, A.; Trujillo-Hernandez, B.; Gamez-Nava, J. I. // Lupus;2004, Vol. 13 Issue 2, p105 

    The aim of this study was to compare the efficacy of intravenous cyclophosphamide (IVCYC) versus oral enalapril in mild or moderate pulmonary hypertension (PH) in systemic lupus erythematosus (SLE). Thirty-four patients with SLEwho had systolic pulmonary artery pressure (SPAP) > 30mmHg by...

  • TROMBEMBOLISM PULMONAR LA ADOLESCENT - PREZENTARE DE CAZ. Lazea, Cecilia; CloŢan, Eufemia Doina; Manasia, Rodica; OpriŢa, Simona // Acta Medica Transilvanica;jun2011, Vol. 16 Issue 2, p65 

    This paper presents the case of a patient aged 17 years who had a syncope after physical exertion. Paraclinical assessment aimed to detect the main causes of the syncope, exogenous causes as well as endogenous neurological, vascular, and metabolic disorders being excluded. Transthoracic...

  • Prevalence of Pulmonary Hypertension in Patients Undergoing Hemodialysis. Fadaii, Abbas; Koohi-Kamali, Homayoun; Bagheri, Bahador; Hamidimanii, Fatemeh; Taherkhanchi, Bahar // Iranian Journal of Kidney Diseases;Jan2013, Vol. 7 Issue 1, p60 

    Introduction. Pulmonary hypertension (PH) is one of the most important accompanying comorbidities with hemodialysis in patients with end-stage renal disease. The prevalence of hemodialysisinduced PH is still a subject of debate. The goal of the present work was to determine the prevalence of PH...

  • Pulmonary Hypertension in Sickle-Cell Disease: Comorbidities and Echocardiographic Findings. Akgül, Ferit; Yalçın, Fatih; Seyfeli, Ergün; Uçar, Edip; Karazincir, Sinem; Balci, Ali; Gali, Edip // Acta Haematologica;Jul2007, Vol. 118 Issue 1, p53 

    Background: Our aim is to determine comorbidities associated with pulmonary hypertension (PHT) in clinically stable sickle-cell disease (SCD) patients and to evaluate left ventricular (LV) and right ventricular (RV) function in those patients. Methods: Echocardiography was performed in 87 SCD...

  • Foreword.  // Current Medical Literature: Pulmonary Hypertension;2012, Vol. 3 Issue 1, pIV 

    A foreword to the "Current Medical Literature: Pulmonary Hypertension" is presented.

  • Empowered Patient Online Toolkit.  // Advances in Pulmonary Hypertension;Summer2012, Vol. 11 Issue 2, p104 

    The article recommends the comprehensive Empowered Patient Toolkit for patients with pulmonary hypertension by Pulmonary Hypertension Association (PHA).

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics